全文获取类型
收费全文 | 99557篇 |
免费 | 42000篇 |
国内免费 | 178篇 |
专业分类
耳鼻咽喉 | 1803篇 |
儿科学 | 4721篇 |
妇产科学 | 940篇 |
基础医学 | 18309篇 |
口腔科学 | 5748篇 |
临床医学 | 13875篇 |
内科学 | 29016篇 |
皮肤病学 | 7882篇 |
神经病学 | 15034篇 |
特种医学 | 2674篇 |
外科学 | 17211篇 |
综合类 | 310篇 |
一般理论 | 31篇 |
预防医学 | 5997篇 |
眼科学 | 1789篇 |
药学 | 6839篇 |
1篇 | |
中国医学 | 1140篇 |
肿瘤学 | 8415篇 |
出版年
2024年 | 21篇 |
2023年 | 202篇 |
2022年 | 517篇 |
2021年 | 2154篇 |
2020年 | 5381篇 |
2019年 | 11389篇 |
2018年 | 10827篇 |
2017年 | 11835篇 |
2016年 | 12483篇 |
2015年 | 12483篇 |
2014年 | 12561篇 |
2013年 | 13290篇 |
2012年 | 5892篇 |
2011年 | 5940篇 |
2010年 | 9831篇 |
2009年 | 6203篇 |
2008年 | 3584篇 |
2007年 | 2399篇 |
2006年 | 2386篇 |
2005年 | 2050篇 |
2004年 | 1894篇 |
2003年 | 1821篇 |
2002年 | 1771篇 |
2001年 | 1072篇 |
2000年 | 983篇 |
1999年 | 540篇 |
1998年 | 234篇 |
1997年 | 191篇 |
1996年 | 157篇 |
1995年 | 128篇 |
1994年 | 121篇 |
1993年 | 93篇 |
1992年 | 152篇 |
1991年 | 132篇 |
1990年 | 117篇 |
1989年 | 74篇 |
1988年 | 60篇 |
1987年 | 55篇 |
1986年 | 65篇 |
1985年 | 45篇 |
1984年 | 47篇 |
1983年 | 29篇 |
1982年 | 55篇 |
1981年 | 40篇 |
1980年 | 32篇 |
1979年 | 23篇 |
1978年 | 31篇 |
1977年 | 23篇 |
1974年 | 37篇 |
1973年 | 29篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Selecting an appropriate working correlation structure is pertinent to clustered data analysis using generalized estimating equations (GEE) because an inappropriate choice will lead to inefficient parameter estimation. We investigate the well‐known criterion of QIC for selecting a working correlation structure, and have found that performance of the QIC is deteriorated by a term that is theoretically independent of the correlation structures but has to be estimated with an error. This leads us to propose a correlation information criterion (CIC) that substantially improves the QIC performance. Extensive simulation studies indicate that the CIC has remarkable improvement in selecting the correct correlation structures. We also illustrate our findings using a data set from the Madras Longitudinal Schizophrenia Study. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
42.
Tsuen‐Chiuan Tsai Peter H Harasym Sylvain Coderre Kevin McLaughlin Tyrone Donnon 《Medical education》2009,43(12):1188-1197
Context The assessment of ethical problem solving in medicine has been controversial and challenging. The purposes of this study were: (i) to create a new instrument to measure doctors’ decisions on and reasoning approach towards resolving ethical problems; (ii) to evaluate the scores generated by the new instrument for their reliability and validity, and (iii) to compare doctors’ ethical reasoning abilities between countries and among medical students, residents and experts. Methods This study used 15 clinical vignettes and the think‐aloud method to identify the processes and components involved in ethical problem solving. Subjects included volunteer ethics experts, postgraduate Year 2 residents and pre‐clerkship medical students. The interview data were coded using the instruments of the decision score and Ethical Reasoning Inventory (ERI). The ERI assessed the quality of ethical reasoning for a particular case (Part I) and for an individual globally across all the vignettes (Part II). Results There were 17 Canadian and 32 Taiwanese subjects. Based on the Canadian standard, the decision scores between Taiwanese and Canadian subjects differed significantly, but made no discrimination among the three levels of expertise. Scores on the ERI Parts I and II, which reflect doctors’ reasoning quality, differed between countries and among different levels of expertise in Taiwan, providing evidence of construct validity. In addition, experts had a greater organised knowledge structure and considered more relevant variables in the process of arriving at ethical decisions than did residents or students. The reliability of ERI scores was 0.70–0.99 on Part I and 0.75–0.80 on Part II. Conclusions Expertise in solving ethical problems could not be differentiated by the decisions made, but could be differentiated according to the reasoning used to make those decisions. The difference between Taiwanese and Canadian experts suggests that cultural considerations come into play in the decisions that are made in the course of providing humane care to patients. 相似文献
43.
Generoso Gómez Cruz Miguel Barrueco Ferrero Irene Aparicio Coca José Ángel Maderuelo Miguel Torrecilla García 《Archivos de bronconeumologia》2009,45(1):16-23
Background and ObjectiveSchool smoking prevention programs have never yielded the expected results. The aim of this study was to analyze the efficacy of an intensive smoking prevention program created by the educational community in which it was to be applied.Population and MethodA 3-year smoking prevention program was carried out among the students of Fuentesaúco Secondary School in Zamora, Spain. The Babilafuente Secondary School in Salamanca, Spain was the control group. The program included both prevention and treatment activities. The former were carried out in the school, in out-of-school situations, and in the community. The questionnaire of the European Smoking Prevention Framework Approach was used.ResultsA total of 417 students aged 12 to 17 years participated in the study. Of these, 54.4% belonged to the intervention group and 45.6% to the control group. Smokers represented 36.7% of the population. After the intervention smokers represented 40.1% of the Fuentesaúco students compared with 46.1% of the Babilafuente students, though the difference was not statistically significant. With respect to the cognitive determinants of smoking behavior, after the intervention significant differences in favor of the intervention group were only observed in the subjects’ perception of the behavior of their siblings, peers, and teachers.ConclusionsThe use of smoking prevention programs in schools should be reconsidered, and their evaluation should be based on educational rather than clinical criteria. Proposed changes in the program include decreasing its intensity, starting with students of an earlier age and seeking greater involvement of parents. 相似文献
44.
45.
Aims To measure the prevalence of low high‐density lipoprotein (HDL)‐cholesterol (men < 1.03 mmol/l; women < 1.29 mmol/l) in European Type 2 diabetic patients receiving treatment for dyslipidaemia. Methods The pan‐European Survey of HDL‐cholesterol measured lipids and other cardiovascular risk factors in 3866 patients with Type 2 diabetes and 4436 non‐diabetic patients undergoing treatment for dyslipidaemia in 11 European countries. Results Diabetic patients were more likely to be obese or hypertensive than non‐diabetic patients. Most patients received lifestyle interventions (87%) and/or a statin (89%); treatment patterns were similar between groups. Diabetic patients had [means (SD)] lower HDL‐cholesterol [1.22 (0.37) vs. 1.35 mmol/l (0.44) vs. non‐diabetic patients, P < 0.001] and higher triglycerides [2.32 (2.10) vs. 1.85 mmol/l (1.60), P < 0.001]. More diabetic vs. non‐diabetic patients had low HDL‐cholesterol (45% vs. 30%), high triglycerides (≥ 1.7 mmol/l; 57% vs. 42%) or both (32% vs. 19%). HDL‐cholesterol < 0.9 mmol/l was observed in 18% of diabetic and 12% of non‐diabetic subjects. Differences between diabetic and non‐diabetic groups were slightly greater for women. LDL‐ and total cholesterol were lower in the diabetic group [3.02 (1.05) vs. 3.30 mmol/l (1.14) and 5.12 (1.32) vs. 5.38 mmol/l (1.34), respectively, P < 0.001 for each]. Conclusions Low HDL‐cholesterol is common in diabetes: one in two diabetic women has low HDL‐cholesterol and one diabetic man in four has very low HDL‐cholesterol. Management strategies should include correction of low HDL‐cholesterol to optimize cardiovascular risk in diabetes. 相似文献
46.
47.
Dr. Joseph A. Paladino Pharm.D. Dr. Miguel A. Rainstein M.D. FACS Mrs. Deborah J. Serrianne R.N. Dr. John E. Przylucki M.D. FACS Dr. Lynda S. Welage Pharm.D. Dr. Mario L. Collura M.D. FACS Dr. Jerome J. Schentag Pharm.D. FCCP 《Pharmacotherapy》1994,14(6):734-739
This double-blind study compared ampicillin-sulbactam 3 g versus cefoxitin 2 g in 136 adult patients at risk for developing an infection after abdominal surgery. Separate randomization schedules were used for colorectal, upper gastrointestinal/biliary, and other abdominal procedures. Study antibiotics were administered within 30 minutes before incision and repeated 6 hours later. Patients having colorectal surgery received a third dose of antibiotic 6 hours after the second. Efficacy evaluations were made on 123 patients, 62 in the ampicillin-sulbactam group and 61 in the cefoxitin group. The overall postoperative infection rates were 12.9% for ampicillin-sulbactam and 9.8% for cefoxitin (p>0.05); one wound infection occurred in each group. Adverse events were experienced by 13.2% of the ampicillin-sulbactam and 19.1% of the cefoxitin recipients (p>0.05). Cost-minimization analysis revealed that ampicillin-sulbactam was a cost-effective alternative to cefoxitin for the prevention of infection after abdominal surgery. 相似文献
48.
49.
50.